Bay Capital agreed to acquire Plenty Biologics Limited, according to source material published on October 20, 2026. The reported purchase consideration is £52,887,070. This summary is limited to the approved transaction facts in the cited source evidence.
Bay Capital agreed to acquire Plenty Biologics Limited
Bay Capital agreed to acquire Plenty Biologics Limited
AcquisitionGBP52,887,070Manufacturing
Get the full Plenty Biologics Limited company profile
Access contacts, investors, buying signals & more
Acquired
Plenty Biologics Limited
Manufacturing
Deal value
GBP52,887,070
October 20, 2026
Acquirer
Bay Capital
Unlock GTM signals
Discover Plenty Biologics Limited's tech stack and active buying intent.
Unlock key decision-makers
Get direct access to the decision-makers at Plenty Biologics Limited.